![Christopher Twitty](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Twitty
Teknisk/Vetenskaplig/F&U Direktör på
SKYE BIOSCIENCE, INC.
Förmögenhet: 16 350 $ per 2026-09-30
Profil
Dr. Christopher G.
Twitty is a Chief Scientific Officer at Skye Bioscience, Inc. Dr. Twitty was previously employed as a Chief Scientific Officer by Onchilles Pharma, Inc., an Independent Director by Larkspur Health Acquisition Corp., and a Chief Scientific Officer, Head-R&D by OncoSec Medical, Inc. He received his undergraduate degree from San Diego State University and a doctorate degree from Oregon Health & Science University.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
SKYE BIOSCIENCE, INC. 0,23 % | 2026-03-31 | 10 155 ( 0,23 % ) | 16 350 $ | 2026-09-30 |
Aktiva positioner av Christopher Twitty
| Företag | Position | Start |
|---|---|---|
| SKYE BIOSCIENCE, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2022-12-13 |
Tidigare kända positioner av Christopher Twitty
| Företag | Position | Slut |
|---|---|---|
Onchilles Pharma, Inc.
 Onchilles Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery and development company | Teknisk/Vetenskaplig/F&U Direktör | 2022-12-01 |
| ONCOSEC MEDICAL INCORPORATED | Teknisk/Vetenskaplig/F&U Direktör | 2021-10-20 |
| LARR HEALPAR | Direktör/Styrelseledamot | - |
Christopher Twittys utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
41
Första gradens relationer
6
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
OncoSec Medical, Inc.
 OncoSec Medical, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel immunotherapeutic products for immuno-oncology treatment | Health Technology |
San Diego State University
 San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oregon Health & Science University
 Oregon Health & Science University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Skye Bioscience, Inc.
 Skye Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets cannabinoid derivatives to treat ophthalmic disorders | Health Technology |
Onchilles Pharma, Inc.
Onchilles Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery and development company | Commercial Services |
Larkspur Health Acquisition Corp.
 Larkspur Health Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
